These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 6810763)
21. Distribution of antibodies to selected antigens of Pseudomonas aeruginosa in children and young adults with cystic fibrosis. Gaweł J; Pogorzelski A; Działek-Smętek E; Sochań B; Ligarska R; Lącka M; Mazurek H Pneumonol Alergol Pol; 2014; 82(4):336-41. PubMed ID: 24964236 [TBL] [Abstract][Full Text] [Related]
23. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Hoiby N Acta Pathol Microbiol Scand Suppl; 1977; (262):1-96. PubMed ID: 411327 [No Abstract] [Full Text] [Related]
24. Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa. Pier GB; Takeda S; Grout M; Markham RB J Clin Invest; 1993 Mar; 91(3):1079-87. PubMed ID: 8450038 [TBL] [Abstract][Full Text] [Related]
25. Circulating immune complexes in cystic fibrosis. Berdischewsky M; Pollack M; Young LS; Chia D; Osher AB; Barnett EV Pediatr Res; 1980 Jun; 14(6):830-3. PubMed ID: 6773019 [TBL] [Abstract][Full Text] [Related]
26. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization]. Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418 [TBL] [Abstract][Full Text] [Related]
28. Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction. Pier GB J Infect Dis; 1985 Apr; 151(4):575-80. PubMed ID: 3919113 [No Abstract] [Full Text] [Related]
29. Pseudomonas aeruginosa allergy in cystic fibrosis. Involvement of histamine release in the pathogenesis of lung tissue damage. Skov PS; Norn S; Schiøtz PO; Permin H; Høiby N Allergy; 1980 Jan; 35(1):23-9. PubMed ID: 6154430 [TBL] [Abstract][Full Text] [Related]
30. Determination of the components of immune complexes made in vitro with antigens derived from Pseudomonas aeruginosa. Kronborg G; Fomsgaard A; Shand GH; Høiby N J Immunol Methods; 1989 Aug; 122(1):51-7. PubMed ID: 2569492 [TBL] [Abstract][Full Text] [Related]
31. Immune complexes in the sputum of patients with cystic fibrosis suffering from chronic Pseudomonas aeruginosa lung infection. Schiøtz PO; Nielsen H; Høiby N; Glikmann G; Svehag SE Acta Pathol Microbiol Scand C; 1978 Feb; 86(1):37-40. PubMed ID: 707104 [TBL] [Abstract][Full Text] [Related]
33. Increased IgG2 and IgG3 concentration is associated with advanced Pseudomonas aeruginosa infection and poor pulmonary function in cystic fibrosis. Pressler T; Mansa B; Jensen T; Pedersen SS; Høiby N; Koch C Acta Paediatr Scand; 1988 Jul; 77(4):576-82. PubMed ID: 3134794 [TBL] [Abstract][Full Text] [Related]
34. Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections: influence of local steroid treatment. Schiøtz PO; Jørgensen M; Flensborg EW; Faerø O; Husby S; Høiby N; Jacobsen SV; Nielsen H; Svehag SE Acta Paediatr Scand; 1983 Mar; 72(2):283-7. PubMed ID: 6340415 [TBL] [Abstract][Full Text] [Related]
35. Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. Assael BM Expert Rev Anti Infect Ther; 2011 Nov; 9(11):967-73. PubMed ID: 22029514 [TBL] [Abstract][Full Text] [Related]
36. An ELISA to detect antipseudomonal IgA antibodies in sera of patients with cystic fibrosis. Brett MM; Ghoneim AT; Littlewood JM J Clin Pathol; 1988 Oct; 41(10):1130-4. PubMed ID: 3142934 [TBL] [Abstract][Full Text] [Related]
37. Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis. Bauernfeind A; Przyklenk B Behring Inst Mitt; 1997 Feb; (98):256-61. PubMed ID: 9382748 [No Abstract] [Full Text] [Related]
38. Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa. Pier GB; Elcock ME J Immunol; 1984 Aug; 133(2):734-9. PubMed ID: 6234359 [TBL] [Abstract][Full Text] [Related]
39. Opsonic defect in patients with cystic fibrosis of the pancreas. Biggar WD; Holmes B; Good RA Proc Natl Acad Sci U S A; 1971 Aug; 68(8):1716-9. PubMed ID: 5001942 [TBL] [Abstract][Full Text] [Related]
40. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide. Fick RB; Olchowski J; Squier SU; Merrill WW; Reynolds HY Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]